Clover Health Investments (FRA:7QD) FFO


FRA:7QD Clover Health Investments Corp FRA:7QD
80 GF Score
Price €4.49
GF Value €3.41
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Clover Health Investments FFO?

FFO (Funds from operations) only applies to REITs.

FRA:7QD
80GF Score
Clover Health Investments Corp FRA:7QD
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clover Health Investments (FRA:7QD) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of €4.49 is trading 31.7% above its estimated GF Value™ of €3.41. GuruFocus considers Clover Health Investments to be Significantly Overvalued.

Key valuation signals for FRA:7QD:

  • FFO:
  • GF Value™: €3.41 vs. price of €4.49 (31.7% above fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the FRA:7QD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clover Health Investments Business Description

Other Exchanges CLOV:USACLOV34:Brazil
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
80GF Score

Get the complete analysis for FRA:7QD

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.49
Price
€3.41
GF Value